Skip to main content
construction release_alert
Scholars@Duke will be undergoing maintenance April 11-15. Some features may be unavailable during this time.
cancel

Long-term follow-up of a controlled trial comparing a combination of methotrexate plus cyclosporine with cyclosporine alone for prophylaxis of graft-versus-host disease in patients administered HLA-identical marrow grafts for leukemia.

Publication ,  Journal Article
Storb, R; Pepe, M; Deeg, HJ; Anasetti, C; Appelbaum, FR; Bensinger, W; Buckner, CD; Cliff, RA; Doney, K; Hansen, J
Published in: Blood
July 15, 1992

Duke Scholars

Published In

Blood

ISSN

0006-4971

Publication Date

July 15, 1992

Volume

80

Issue

2

Start / End Page

560 / 561

Location

United States

Related Subject Headings

  • Time Factors
  • Methotrexate
  • Leukemia, Myeloid, Acute
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive
  • Leukemia
  • Immunology
  • Humans
  • Histocompatibility Testing
  • HLA Antigens
  • Graft vs Host Disease
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Storb, R., M. Pepe, H. J. Deeg, C. Anasetti, F. R. Appelbaum, W. Bensinger, C. D. Buckner, R. A. Cliff, K. Doney, and J. Hansen. “Long-term follow-up of a controlled trial comparing a combination of methotrexate plus cyclosporine with cyclosporine alone for prophylaxis of graft-versus-host disease in patients administered HLA-identical marrow grafts for leukemia.Blood 80, no. 2 (July 15, 1992): 560–61.

Published In

Blood

ISSN

0006-4971

Publication Date

July 15, 1992

Volume

80

Issue

2

Start / End Page

560 / 561

Location

United States

Related Subject Headings

  • Time Factors
  • Methotrexate
  • Leukemia, Myeloid, Acute
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive
  • Leukemia
  • Immunology
  • Humans
  • Histocompatibility Testing
  • HLA Antigens
  • Graft vs Host Disease